Benzinga··Vandana SinghCRISPR Therapeutics Posts Strong Gene Therapy Gains as Casgevy Adoption Accelerates
CRISPR Therapeutics reports strong Q4 results with Casgevy gene therapy generating $116M revenue and 147 patient initiations, signaling accelerating adoption and market confidence.
LLYVRTXREGNCRSPARWRsickle cell diseaseCasgevy